2023
DOI: 10.1101/2023.08.01.23293521
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Diagnostic performance of LumiraDx SARS-CoV-2 rapid antigen test compared to PCR for diagnosis of COVID-19 in Liberia

Moses Badio,
Christina Lindan,
Kumblytee Johnson
et al.

Abstract: BackgroundDiagnosis of SARS-CoV-2 infection in Liberia has primarily relied on polymerase chain reaction (PCR)-based testing at the country’s National Reference Laboratory. This centralized approach caused reporting delays, prompting evaluation of point-of-care antigen-based tests. We assessed the test performance of the LumiraDx™ SARS-CoV-2 Ag test (LumiraDx™, London, UK) in this setting.MethodsWe tested ambulatory individuals screened for enrollment into an observational cohort study of COVID-19 sequelae in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 20 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?